Rostami, SinaPasdar, AlirezaGerayli, SinaHatami, HamedSepahi, SamanehNategh, FatemehMeshkat, MojtabaHoseini, Seyed MousalrezaAhadi, MitraSima, Hamid RezaVosughinia, HasanSarvghad, Mohammad RezaEsmaeelzade, AbbasNomani, HoseinMozafari, Homan MosananTalab, Fariba RezaiShakeri, Mohammad TaghiMeshkat, Zahra2020-12-162020-12-162017-06-01Rostami, S, Pasdar, A, Gerayli, S, Hatami, H, Sepahi, S, Nategh, F, Meshkat, M, Hoseini, S M, Ahadi, M, Sima, H R, Vosughinia, H, Sarvghad, M R, Esmaeelzade, A, Nomani, H, Mozafari, H M, Talab, F R, Shakeri, M T & Meshkat, Z 2017, 'Comparison of Interferon-Gamma (IFNG) +874 T/A single nucleotide polymorphism in hepatitis C virus infected patients and non-infected controls in Mashhad, Iran', Iranian Journal of Pathology, vol. 12, no. 3, pp. 248-256. < https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835373/ >1735-5303ORCID: /0000-0002-7864-9729/work/86450476https://hdl.handle.net/2164/15532This study was financially supported by Mashhad University of Medical Sciences, Mashhad, Iran (Grant No. 900513).9437048engSDG 3 - Good Health and Well-beingHepatitis C virusInterferon-gammaPolymorphismSingle nucleotideR MedicinePathology and Forensic MedicineRComparison of Interferon-Gamma (IFNG) +874 T/A single nucleotide polymorphism in hepatitis C virus infected patients and non-infected controls in Mashhad, IranJournal articlehttp://www.scopus.com/inward/record.url?scp=85027047327&partnerID=8YFLogxKhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835373/123